Shortlist Unveiled For GGB Awards
Contenders Revealed Ahead Of 2 November Ceremony In Frankfurt
The final shortlist of contenders has been unveiled for the Global Generics & Biosimilars Awards 2022, which returns to Frankfurt on 2 November.
You may also be interested in...
Icelandic out-licensing and contract manufacturing firm Coripharma is moving from the start-up phase to fully-fledged growth, with a particular focus on niche generics and a firm eye on environmental and sustainability aspects, CEO Jónína Guðmundsdóttir tells Generics Bulletin.
Looking back over the third quarter of 2022, Generics Bulletin executive editor Dave Wallace picks out highlights from July to September that include changes in ownership on the horizon for major industry players, executive reshuffles at the top of leading companies and regulators, Generics Bulletin’s annual Top 50 and the announcement of our annual awards shortlist.
Shreehas Tambe has been named as CEO of Biocon Biologics, taking over from Arun Chandavarkar, in the wake of the company’s milestone $3bn transaction for Viatris’s biosimilars business.